The clinical characteristics and neuropathological findings of 22 organ transplant recipients with CNS aspergillosis were reviewed. Thirteen patients had liver, six kidney, two heart and one had cluster transplants. The most frequent neurological symptoms were alteration of mental status (86%), seizures (41%) and focal neurological deficits (32%). Meningeal signs were less common (19%). Aspergillus spp invasion of the blood vessels with subsequent ischaemic or haemorrhagic infarcts, and solitary or multiple abscesses were the predominant neuropathological findings. The lungs were the probable portal of entry; however, isolated CNS aspergillosis was seen in two patients. Antemortem diagnosis of the infection was made in half of the patients. Concomitant diabetes mellitus was noted in 590/o of the patients and bacterial or other severe infections in 86%. No specific clinical or pathological pattern could be identified among patients with different types of organ transplants. In addition CNS aspergillosis was preceded by organ rejection and the need for intense immunosuppression and retransplantation in the majority of the patients.
12 patients who had an orthotopic liver transplantation, five patients with kidney transplantations, two with heart transplantations, and one patient with an abdominal cluster transplantation, which involved en-block replacement with liver, pancreas and small bowel. The two diagnosed by biopsy included: one patient with a liver transplantation and another with kidney transplantation. Although both patients died subsequently, necropsy was not performed.
Our patients were selected from among the 218 transplant patients who had complete necropsy carried out at the UPMC from January 1981 to December 1990; this included 112 liver, 19 kidney, 84 heart and 3 cluster transplant patients. Of 4448 patients who had organ transplantation at the UPMC during that time, 2180 had liver, 1714 kidney, 538 heart and 16 had cluster transplants.
Methods
The clinical records were reviewed by an internist (JTC) and a neurologist (OL) in each case to identify and characterise the neurological events. Clinical parameters recorded included any alteration of the mental status, seizures, focal neurological symptoms and meningism. Mental status alteration was considered to be rapidly progressive when it evolved within 24 hours and progressive when it evolved over 24 hours. CT scans of the head, EEGs, laboratory and other specific neuroradiological reports were reviewed when pertinent.
Standard immunosuppressive protocols consisting of Cyclosporin A (CyA) and prednisone have been published previously. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Serum levels of CyA were determined routinely, with therapeutic level ranging from 600 to 1000 ng/ml. Azathioprine was frequently used in combination with CyA and prednisone. Rejection episodes were managed with methylprednisolone as 1 gram intravenous bolus or 1 gram daily for 5 days. A monoclonal anti-lymphocyte globulin (OKT3) was occasionally used to treat steroid resistant rejection episodes. Rabbit antithymocyte globulin (RATG) was administered to one heart transplant patient.
The underlying diagnoses of liver transplant recipients were: a) fulminant hepatitis (three cases); b) Hepatitis B Virus cirrhosis (two cases); c) autoimmune cirrhosis (two cases); d) cirrhosis of unknown aetiology (three cases); e) primary biliary cirrhosis (two cases) and f) Budd-Chiari syndrome (one case). In kidney transplant patients the diagnoses were: a) hypertensive nephropathy (three cases); b) polycystic kidney disease (one case); c) systemic lupus erythematosus nephropathy (one case) and d) chronic renal failure of unknown aetiology (one case). In heart transplant patients the diagnoses were: a) atherosclerotic heart disease (one case) and b) dilated cardiomyopathy (one case).
Neuropathological methods used in transplant recipients and brain biopsy procedures have been described in detail previUSly.2 3 15-17 Results Cerebral and cerebellar abscesses composed of necrotic CNS parenchyma with minimal acute and chronic inflammatory reaction and the presence of hyphae were observed in three patients (15%) at necropsy (figure C), and in 14 cases, and six of the nine cases occurred in the first month. There were four cases occurring after the first year, and three were liver transplants. Only one liver transplant patient developed CNS aspergillosis between the second month and one year after transplant. Of the six cases after kidney transplant, four cases occurred in the second and third month. Aspergillosis occurred in a constant rate throughout the year. Twelve episodes occurred between November and April and 10 between May and October. The duration of surgery ranged from 10-38 hours [mean (SD): 22 (9 6 ) hours] and in 12 cases (92%) was more than 12 hours.
NEUROPATHOLOGY
CNS aspergillosis was observed following intense anti-rejection therapy in 18 patients (82%). Nine patients (41%) were treated with antilymphocyte globulin, nine (41%) with boluses of steroids and 14 (64%) with recycles of steroids. Rabbit anti-thymocyte globulin was administered to one patient (4%). Combined antirejection therapy with two or more of these agents was used in 12 patients (54%). Eleven patients had more than one transplant (50%). They were 10 of 13 liver transplant patients (77%) and one of six kidney transplant patients (17%).
CNS aspergillosis was associated with at least one systemic infection in 19 patients (86%) and with multiple infections in 11 (50%) of those patients. Systemic infections included: cytomegalovirus (CMV) disease (seven cases), peritonitis (eight cases), sepsis of unknown origin (five cases), pneumonia (three cases), hepatitis B virus (two cases), systemic candidiasis (one case), herpes simplex virus (HSV) disease (one case), human immunodeficiency virus (HIV) infection (one case) and otitis media (one case). The last patient deveioped an acute purulent meningitis secondary to the ear infection which was concurrent with the CNS aspergillosis.
All but one patient received additional intravenous antibiotics two months before the infection. The duration of the treatment with antibiotics ranged from five to 70 days [mean (SD): 19-6 (19-7) days].
Cerebral haemorrhagic events in the presence of coagulopathy were observed in 11 patients, while six patients had coagulopathy without haemorrhages. Uncontrolled diabetes was found in 13 patients (59%) and nine had received liver grafts.
Discussion
This retrospective study of 22 organ transplant patients with CNS aspergillosis indicates that the most common neurological symptoms were alteration of mental status, seizures and focal motor deficits. The main neuropathological finding was fungal invasion of the wall of the cerebral blood vessel with thrombosis and subsequent ischaemic or haemorrhagic infarcts and subdural or subarachnoid haemorrhages. No specific clinical or pathological pattern of the infection could be observed among patients with different types of organ transplantation.
Organ transplant recipients are at risk of systemic and CNS aspergillosis. Estimates of frequency of aspergillosis after organ transplant have varied from 1-10%,'°'8 19 with CNS involvement in 10-50% of those patients. 20.22 In this study, approximately 9% of the 218 patients where necropsy was carried out had aspergillosis. The infection was observed in 11 % of liver transplant, 26% of kidney transplant and 2% of heart transplant patients. Although aspergillosis seemed to be more frequent in kidney transplant patients, these figures represent only patients in whom necropsy was performed, consequently they may overestimate the actual rate of CNS aspergillosis.
The most important clinical symptom observed in these patients was alteration of mental status. Whether these findings were a direct consequence of CNS aspergillosis or due to the frequent metabolic abnormalities seen in these patients was difficult to evaluate. In addition, these patients had other risk factors directly related to the transplant process. Primary organ dysfunction exerts an important effect on mental status, and encephalopathy and coma are not uncommon findings in patients under immunosuppressive therapy. 23 27 However, CNS structural lesions such as abscesses, haemorrhages and infarcts played an important role in the onset of seizures in this series. Focal motor deficits were also common and were often associated with vascular lesions or abscesses. The predilection of Aspergillus spp for invasion of blood vessel walls with subsequent thrombosis, infarcts and haemorrhages explain, in part, the focal motor deficits. This tendency to invade blood vessels has been described previously,4 including the uncommon finding of ruptured Aspergillus mycotic aneurysms. In addition, coagulopathy is another common occurrence in transplant patients (for example, liver transplant),28 and was seen in 77% of patients in this series. Thus the combination of fungal invasion of cerebral blood vessels and coagulopathy were the probable mechanism of cerebral bleeding and the underlying cause of focal motor deficits in these patients.
Meningeal signs such as headaches, Brudzinski's sign and Kernig's sign were uncommon, occurring in four patients. They were related to Aspergillus spp leptomeningitis in one case, bacterial leptomeningitis in two cases, and to subarachnoid haemorrhage secondary to a rupture mycotic aneurysm in another case. The paucity of meningeal signs in this study could be explained by the tendency of the fungus to invade subcortical vessels. 4 Aspergillus spp are primary respiratory pathogens, and the lungs are the main portal of entry of disseminated infection.' In contrast to previous reports of CNS aspergillosis originating in the lungs,5 we were unable to identify the source of infection in two patients. In immunocompromised patients other sources such as skin and paranasal sinuses should be considered.' No patient demonstrated skin abnormalities in this series, however, sinus examination was not specifically addressed at necropsy in most of these patients.
The majority of CNS aspergillosis occurred within the first three months after organ transplantation which is the most critical period for severe infection in general.29 30 Liver transplant patients had earlier onset of symptoms compared with other transplant recipients. A second peak of incidence was observed after the first year and was associated with chronic rejection and/or retransplantation during a period of intense immunosuppression. In addition, we did not find the seasonal incidence reported in previous studies. 5 The 
